Results 41 to 50 of about 11,993 (190)

Progress report on new epilepsy treatments: A summary of the Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII). I. Treatments in preclinical and early clinical development

Epilepsia, EarlyView.
Abstract Over the last 34 years, the Eilat Conference on New Antiepileptic Drugs and Devices has provided an interactive forum for stakeholders to discuss investigational and recently licensed treatments for seizures and epilepsy. The Eighteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVIII) took place in Madrid, Spain, on May 3 ...
Meir Bialer, Cecilie Johannessen Landmark, Matthias J. Koepp, Emilio Perucca, Piero Perucca, Torbjörn Tomson, H. Steve White, Elaine Wirrell   +7 more
wiley   +1 more source

Chemical analysis and concentrations of cannabidiol substances used for refractory epilepsy in Chilean patients. An underestimated worldwide risk

Epilepsia Open
Objective The purpose of this study is to analyze composition of HMS (homemade CBD), NLS (non‐licensed commercial products), and bioequivalent CBD (BES) collected from Chilean patients that voluntary accepted to analyze the “CBD‐substance.” Methods ...
Loreto Ríos‐Pohl, Macarena Franco, Daniel Navea, Viviana Venegas, Tomás Cerda   +4 more
doaj   +1 more source

WONOEP appraisal: Biomarkers and treatment strategies beyond the synapse

Epilepsia, EarlyView.
Abstract Epilepsy is a heterogeneous neurological disorder affecting more than 70 million people worldwide, posing significant challenges for clinicians due to its complex etiology, diverse manifestations, variable treatment responses, and the inability to predict seizures or disease onset reliably.
Mirte Scheper, Zining Liu, Aristea S. Galanopoulou, Gernot Hlauschek, Benjamin Sinclair, Wai Lam Leung, Stefanie Dedeurwaerdere, Elisabeth Doran, Solomon L. Moshé, David C. Henshall, Ozlem Akman, Pablo M. Casillas‐Espinosa   +11 more
wiley   +1 more source

Treatment simplification to optimize cenobamate effectiveness and tolerability: A real‐world retrospective study in Spain

Epilepsia Open
Objective This study aimed to explore the impact of co‐antiseizure medication (co‐ASM) optimization on the effectiveness and tolerability of adjunctive cenobamate (CNB) in patients with drug‐resistant epilepsy in a real‐world setting.
Juan Jesús Rodríguez‐Uranga, Juan María Sánchez‐Caro, Roshan Hariramani Ramchandani   +2 more
doaj   +1 more source

EEG de superficie y de actividad epileptiforme interictal en niños y adolescentes con diagnóstico de epilepsia

Acta Neurológica Colombiana, 2013
Introducción: los estudios de electroencefalografía (EEG) constituyen la técnica de elección para diagnóstico y clasificación de las epilepsias. Objetivo:determinar los hallazgos electroenefalográficos de superficie en pacientes pediátricos con ...
Francisco Cabrera P, Randy Guerra O, Franky J Fandiño, Andrés Barrios L   +3 more
doaj   +2 more sources

Inherited metabolic epilepsies–established diseases, new approaches

Epilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Demographic and social profile of epilepsy in a vulnerable low-income population in Bogotá, Colombia

Neurología (English Edition), 2016
Introduction: Very few studies describe the demographic and social profile of epilepsy in vulnerable low-income populations. Methods: Observational, descriptive, cross-sectional study prospectively recording data from all patients diagnosed with epilepsy
C.A. Espinosa Jovel, C.M. Pardo, C.M. Moreno, J. Vergara, D. Hedmont, F.E. Sobrino Mejía   +5 more
doaj   +1 more source

Epilepsy syndromes classification

Epilepsia Open, EarlyView.
Abstract Epilepsy syndromes are distinct electroclinical entities which have been recently defined by the International League Against Epilepsy Nosology and Definitions Task Force. Each syndrome is associated with “a characteristic cluster of clinical and EEG features, often supported by specific etiologic findings”.
Elaine C. Wirrell, Nicola Specchio, Rima Nabbout, Phillip L. Pearl, Kate Riney   +4 more
wiley   +1 more source

Frecuencia de Síntomas de Depresión en Pacientes Adolescentes con Epilepsia. Tratados en el Servicio de Consulta Externa de la Fundación Hospital de la Misericordia y Fundación Liga Central Contra La Epilepsia

Medicina, 2009
<p><span>*Este artículo está basado en la tesis de especialización de Carolina Ñungo bajo la dirección del segundo y tercer autor. Fragmentos de este artículo fueron presentados como poster en el XIV Congreso Nacional de Epilepsia en Medellín,
Carolina Ñungo, Adolfo Álvarez, Rafael Vásquez, Mauricio Espitia, Carlos Medina Malo, Álvaro Izquierdo   +5 more
doaj  

Genetic epilepsies with myoclonic seizures: Mechanisms and syndromes

Epilepsia Open, EarlyView.
Abstract Genetic epilepsy with myoclonic seizures encompasses a heterogeneous spectrum of conditions, ranging from benign and self‐limiting forms to severe, progressive disorders. While their causes are diverse, a significant proportion stems from genetic abnormalities.
Antonietta Coppola, Marica Rubino, Antonella Riva, Pasquale Striano   +3 more
wiley   +1 more source